| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/09553000701558985 |
| P698 | PubMed publication ID | 17729162 |
| P50 | author | Berend J Slotman | Q40690934 |
| P2093 | author name string | Peter Sminia | |
| Jaap van den Berg | |||
| M Vincent M Lafleur | |||
| Laurine E Wedekind | |||
| T Rianne Stoter | |||
| Gitta K Kuipers | |||
| P2860 | cites work | Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance | Q47753382 |
| Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo | Q48114757 | ||
| Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme | Q48794947 | ||
| Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors | Q49107944 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. | Q27863328 | ||
| Cyclooxygenase-2 as a target for anticancer drug development | Q28195645 | ||
| Cyclooxygenases in cancer: progress and perspective | Q28213081 | ||
| Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen | Q31634572 | ||
| Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse | Q34418299 | ||
| Many actions of cyclooxygenase-2 in cellular dynamics and in cancer | Q34539982 | ||
| Clonogenic assay of cells in vitro. | Q34615431 | ||
| Enhancing Radiotherapy With Cyclooxygenase-2 Enzyme Inhibitors: A Rational Advance? | Q35547507 | ||
| Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors | Q36498885 | ||
| Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels | Q40360880 | ||
| Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxib | Q40372237 | ||
| Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines | Q40598873 | ||
| Cyclooxygenase-2 (COX-2) expression by immunohistochemistry in glioblastoma multiforme | Q44045025 | ||
| In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations | Q44177730 | ||
| Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells. | Q44610282 | ||
| Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors | Q44748389 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 677-685 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | International Journal of Radiation Biology | Q2093427 |
| P1476 | title | Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration | |
| P478 | volume | 83 |
| Q41090290 | 4-(Nitrophenylsulfonyl)piperazines mitigate radiation damage to multiple tissues. |
| Q39875396 | A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells |
| Q39630225 | A role for MT1-MMP as a cell death sensor/effector through the regulation of endoplasmic reticulum stress in U87 glioblastoma cells |
| Q34361606 | Anti-cancer effects of celecoxib on nasopharyngeal carcinoma HNE-1 cells expressing COX-2 oncoprotein |
| Q55463690 | Anti-tumour effects by a trimodal combination of temozolomide, meloxicam and X-rays in cultures of human glioma cells. |
| Q47127252 | Association between nonsteroidal anti-inflammatory drugs use and risk of central nervous system tumors: a dose-response meta analysis |
| Q41866357 | COX-2 Inhibition Combined with Radiation Reduces Orthotopic Glioma Outgrowth by Targeting the Tumor Vasculature. |
| Q53288733 | COX2 expression predicts resistance to chemoradiotherapy in esophageal squamous cell carcinoma. |
| Q39696393 | Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells. |
| Q54484439 | Concanavalin-A triggers inflammatory response through JAK/STAT3 signalling and modulates MT1-MMP regulation of COX-2 in mesenchymal stromal cells. |
| Q38969912 | Cyclooxygenase-2 in glioblastoma multiforme |
| Q93080077 | Hydrogen Ion Dynamics of Cancer and a New Molecular, Biochemical and Metabolic Approach to the Etiopathogenesis and Treatment of Brain Malignancies |
| Q38704729 | Moschamine inhibits proliferation of glioblastoma cells via cell cycle arrest and apoptosis |
| Q36005646 | Radiation, inflammation, and immune responses in cancer |
| Q38009199 | Stimulatory action of cyclooxygenase inhibitors on hematopoiesis: a review. |
| Q39703957 | Strategies for the analysis of in vitro radiation sensitivity and prediction of interaction with potential radiation modifying agents |
| Q37685102 | Tetrandrine Exerts a Radiosensitization Effect on Human Glioma through Inhibiting Proliferation by Attenuating ERK Phosphorylation |
| Q33651146 | The lectin concanavalin-A signals MT1-MMP catalytic independent induction of COX-2 through an IKKgamma/NF-kappaB-dependent pathway |
| Q37107205 | Transcription factor interactions mediate EGF-dependent COX-2 expression |
| Q35922107 | Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma |
Search more.